SureTrader
Home > Boards > US Listed > Biotechs >

AEterna Zentaris Inc. (AEZS)

AEZS RSS Feed
Add AEZS Price Alert      Hide Sticky   Hide Intro
Moderator: alexander77, chmcnfunds
Search This Board:
Last Post: 8/23/2016 11:05:16 PM - Followers: 347 - Board type: Free - Posts Today: 0

http://aezsinc.com/portfolio/r-d-programs
 

 


 

Corporate Profile


Æterna Zentaris Inc. (TSX:  AEZ, NASDAQ:  AEZS) is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer.The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options.

http://www.aezsinc.com/en/index.php

 

  Pipeline:
           
           http://aezsinc.com/portfolio/r-d-programs              


News:

Yahoo feed:

http://finance.yahoo.com/q?s=aezs&ql=1 

iHub feed:

http://ih.advfn.com/p.php?pid=news&symbol=N%5EAEZS


Contact us:

Canada
Norton Rose Fulbright Canada, LLP
1 Place Marie, Suite 2500
Montreal (Quebec), H3B 1R1
Canada

USA
Aeterna Zentaris, Inc.
315 Sigma Drive, Suite 302D
Summerville, SC 29483
Phone: (843) 900-3223

Germany
Aeterna Zentaris GmbH
Weismüllerstrasse 50
60314 Frankfurt
Germany
Phone: +49 69 42602 3228 

Investor Fact Sheet: (May, 2016)

        http://ir.aezsinc.com/sites/aezsinc.investorhq.businesswire.com/files/doc_library/file/AEZS_IR_Fact_Sheet_May_2016.pdf ;     
 
Corporate Presentation: (March 31, 2016)

http://ir.aezsinc.com/sites/aezsinc.investorhq.businesswire.com/files/doc_library/file/Q4_2015_Analyst_Call_PRESENTATION_FINAL_3_23_2016_1.pdf

Website:    
  

                                                         http://www.aeternazentaris.com                                                                    


Clinical Trials:

http://clinicaltrials.gov/ct2/results?term=AEZS&Search=Search

Charts:

Gallery views:

http://stockcharts.com/freecharts/gallery.html?aezs



Daily three months:

   
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AEZS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
AEZS News: Aeterna Zentaris Reports Second Quarter 2016 Financial and Operating Results 08/09/2016 04:30:00 PM
AEZS News: Aeterna Zentaris Expands Promotion of APIFINY® into Florida 08/08/2016 08:30:00 AM
AEZS News: Aeterna Zentaris and Rafa Laboratories Sign Exclusive License Agreement for Zoptrex™ in Israel 08/01/2016 08:30:00 AM
AEZS News: Aeterna Zentaris to Announce Second Quarter 2016 Financial and Operating Results on August 9, 2016 07/27/2016 08:30:00 AM
AEZS News: Aeterna Zentaris and Orient EuroPharma Co., Ltd. Sign Exclusive License Agreement for Zoptrex™ in Taiwan and Southeast Asia 07/01/2016 08:30:00 AM
PostSubject
#15340  Sticky Note Aeterna Zentaris' (AEZS) CEO David Dodd on Q2 chmcnfunds 08/11/16 11:16:06 AM
#15274  Sticky Note AEZS may generate $27/share annual revenues alexander77 04/05/16 03:42:18 AM
#15356   Seems like volume is about 1/2 what is MR 1955 DOUBLE DIE 08/23/16 11:05:16 PM
#15355   Thsnks for your opinion. Great dd MR 1955 DOUBLE DIE 08/16/16 11:37:31 AM
#15354   It seems to be ongoing. Looks to me chmcnfunds 08/16/16 11:33:57 AM
#15353   What about the 10 million they did in MR 1955 DOUBLE DIE 08/15/16 04:55:51 PM
#15352   Generally in the short term as the offering chmcnfunds 08/15/16 01:51:37 PM
#15351   Will that negatively impact the stock? Jclassy 08/15/16 01:42:00 PM
#15350   Was a crazy day. From the sidelines couldn't chmcnfunds 08/15/16 01:20:18 PM
#15349   The offering already occurred in my opinion, the Jclassy 08/15/16 01:03:14 PM
#15348   you know inside and out of AEZS :) ~ kei 08/15/16 12:20:23 PM
#15347   Two recent analyst's inputs: chmcnfunds 08/15/16 11:54:07 AM
#15346   Took a look at Dodd's conference call (quick chmcnfunds 08/15/16 10:46:11 AM
#15345   thank you for the reply! no share here..the kei 08/15/16 09:27:44 AM
#15344   Hello. Of course bullish on AEZS. Aren't you chmcnfunds 08/15/16 09:13:44 AM
#15343   hello chmcnfunds!! how are you? are you bullish kei 08/14/16 11:10:17 AM
#15342   Anyone expect this to head north soon? MR 1955 DOUBLE DIE 08/13/16 04:08:05 PM
#15341   AEZS bullish 3.57 stocktrademan 08/12/16 12:16:10 PM
#15340   Aeterna Zentaris' (AEZS) CEO David Dodd on Q2 chmcnfunds 08/11/16 11:16:06 AM
#15339   Still waiting on the major testing results due osu78OnFire 08/08/16 11:17:06 AM
#15338   Aeterna Zentaris Expands Promotion of APIFINY® into Florida chmcnfunds 08/08/16 08:48:12 AM
#15337   David Dodd, President and CEO of the Company, doogdilinger 08/01/16 10:00:50 AM
#15336   Aeterna Zentaris and Rafa Laboratories Sign Exclusive License chmcnfunds 08/01/16 08:41:45 AM
#15335   Aeterna Zentaris to Announce Second Quarter 2016 Financial chmcnfunds 07/27/16 09:02:27 AM
#15334   That would require a form 4. Android 2-73 07/27/16 08:15:07 AM
#15333   but we do not know if he sold joelk 07/25/16 05:46:48 PM
#15332   CEO has been buying shares this year periodically. Android 2-73 07/25/16 03:25:06 PM
#15331   it seems to me if there was a joelk 07/25/16 02:49:09 PM
#15330   Thanks for the reply. I see Aezs MR 1955 DOUBLE DIE 07/24/16 05:48:18 PM
#15329   no. Actually the shorts beat it down the Android 2-73 07/24/16 03:24:07 PM
#15328   Did cpxx have a run up before data? MR 1955 DOUBLE DIE 07/22/16 10:50:20 PM
#15327   Yes but I don't plan to have any MR 1955 DOUBLE DIE 07/22/16 10:48:29 PM
#15326   should be, but markets are irrational. CPXX was Android 2-73 07/22/16 10:45:56 PM
#15325   Stock should have a nice run up very MR 1955 DOUBLE DIE 07/22/16 08:34:49 PM
#15324   Phase 3 data out by September 30th in Android 2-73 07/22/16 04:04:15 PM
#15323   Hopefully we will see soon! :) Outlaw 07/14/16 10:29:35 PM
#15322   not sure if it is undervalued, I joelk 07/14/16 10:27:28 PM
#15321   AEZS - Extremely undervalued... Outlaw 07/12/16 11:54:42 PM
#15320   AEZS:$12/share target reaffirmed+institutional buying alexander77 07/12/16 12:54:06 AM
#15319   Thank you alexander77 07/11/16 10:19:38 AM
#15318   Agreed! Great post MR 1955 DOUBLE DIE 07/10/16 07:01:25 PM
#15317   Strong cash position $33m as of March 31st, alexander77 07/09/16 03:23:18 AM
#15316   * * $AEZS Video Chart 07-01-16 * * ClayTrader 07/01/16 04:48:25 PM
#15315   Awesome alexander:) doogdilinger 07/01/16 09:35:16 AM
#15314   Another partnership for Zoptrex,now for Taiwan and Southasia!! alexander77 07/01/16 08:52:41 AM
#15313   Nice mornin' so far doogdilinger 06/15/16 11:02:08 AM
#15312   Aeterna Zentaris Announces IND Submission by Sinopharm A-Think chmcnfunds 06/15/16 07:58:03 AM
#15311   I am incredibly intrigued by the apparent value jklein 06/07/16 04:10:33 PM
#15310   Absolutely. Three products they sell and two products alexander77 06/07/16 03:00:14 PM
#15309   I've been holding at .036 before the reverse jaconow 06/07/16 08:18:45 AM
#15308   Yes, I agree. alexander77 06/06/16 03:47:31 PM
#15307   This should pop once the company prs that MR 1955 DOUBLE DIE 06/04/16 11:42:13 AM
PostSubject